## CB: Chubb Limited - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.2% below STRENGTH zone (3.0-6.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($301.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. How Investors Are Reacting To Chubb (CB) Bolstering Global P&C Leadership For International Expansion**
- Source: Simply Wall Street | 20251220T123847 | Somewhat-Bullish | Relevance: 100%
- Chubb Limited has appointed new leadership, Aaron Shead and Chris Colahan, to strengthen its international property and casualty operations, particularly focusing on growth in Asia Pacific. This move highlights Chubb's strategy for global expansion and disciplined underwriting, though investors are wary of potential earnings volatility from catastrophes and social inflation. The article discusses how these leadership changes fit into Chubb's longer-term earnings profile and fair value projections.

**2. How Investors Are Reacting To Chubb (CB) Bolstering Global P&C Leadership For International Expansion**
- Source: Simply Wall Street | 20251220T130750 | Somewhat-Bullish | Relevance: 100%
- Chubb Limited appointed Aaron Shead and Chris Colahan to lead international property and Asia Pacific Commercial Property Casualty, respectively, to strengthen global growth and disciplined underwriting. While these appointments are seen as incremental, they highlight Chubb's focus on international expansion, especially in higher-growth regions. Investors are assessing how these leadership changes and execution in higher-risk regions will impact future profitability and valuation, despite potential earnings volatility from catastrophes and social inflation.

**3. Leading US insurer Chubb plans to exit Myanmar**
- Source: elevenmyanmar.com | 20251220T120734 | Bearish | Relevance: 100%
- Chubb, a prominent American insurance company, is reportedly planning to exit Myanmar after six years of operation, leading to criticism from customers and concerns within the local insurance industry. The company cited operational challenges and the economic environment as reasons for surrendering its insurance license and closing representative offices, promising 100% premium refunds for policies valid until December 15. This withdrawal has sparked debate among insurance agents and policyholders about customer protection, inflation impacts, and the responsibilities of international firms.

**4. Assenagon Asset Management S.A. Raises Holdings in Chubb Limited $CB**
- Source: MarketBeat | 20251220T084836 | Somewhat-Bullish | Relevance: 100%
- Assenagon Asset Management S.A. significantly increased its stake in Chubb Limited (NYSE:CB) by 599.1% during the third quarter, now owning 73,025 shares valued at $20.61 million. This move is part of broader institutional interest in Chubb, with other firms also adjusting their positions. The article also details recent insider stock sales, Chubb's financial performance, and upcoming dividend information.

**5. Healthy Paws Pet Foundation at Chubb Donates $275,000 to Animal Rescue Organizations Across the United States to Support Adoption and Ongoing Care for Vulnerable Pets**
- Source: Finviz | 20251222T100000 | Somewhat-Bullish | Relevance: 100%
- The Healthy Paws Pet Foundation at Chubb has donated a total of $275,000 to seven animal rescue organizations across the United States. These funds are intended to support pet adoption and ongoing care for vulnerable animals, helping the recipient organizations expand their lifesaving initiatives and find forever homes for pets. This initiative underscores Healthy Paws' commitment to facilitating pet rescue and care, from adoption through veterinary visits and ongoing medical needs.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $318 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($14.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.3%)
- Berkshire Hathaway, : 7.6% (+15.9%)
- Blackrock Inc.: 6.7% (+0.6%)
- State Street Corpora: 4.1% (+0.4%)
- FMR, LLC: 3.0% (-11.2%)

### Key Risks

1. Heavy insider selling: $15M sold (7 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (10.9x). Insider selling cluster ($14.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $124.0B |
| Beta | 0.52 |
| 52W Range | $252.16 - $313.46 |
| Short Interest | 0.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 11.8 |
| Current P/E | 13.1 |
| YoY Growth | 11.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 4.7% to 0.2% (-4.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.8pp (needs >3.0% for momentum thesis). MRS_5 (-1.5%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.64), confirming momentum. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.22% (CS: 56) | Neutral |
| RSI_14 | 67.4 | Neutral |
| MACD Histogram | 0.64 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.068x | Above |
| vs SMA200 | 1.091x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $310.82
- **Stop Loss:** $301.74 (2.9% risk)
- **Target:** $319.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 99
- **Position Value:** $30,771.18
- **Portfolio %:** 30.77%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-27 (Est: $6.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.16 | $7.49 | +21.7% |
| 2025Q2 | $5.97 | $6.14 | +2.8% |
| 2025Q1 | $3.23 | $3.68 | +14.0% |
| 2024Q4 | $5.45 | $6.02 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*